PharmaGroup ApS: Financial statements 2024
CVR: 43324667
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PharmaGroup ApS (CVR 43324667) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 9,046,929 and a net result of DKK 5,037,144 compared with DKK 5,447,761 the year before. That is an increase of 3.1% compared with the year before. Equity in the 2024 report amounted to DKK 5,091,532. The solvency ratio was 65.9%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 9,046,929
- Profit/Loss
- DKK 5,037,144
- Equity
- DKK 5,091,532
- Total Assets
- DKK 7,729,252
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 9M | 5M | 5.1M | 4 |
| 2023 | - | 8.8M | 5.4M | 7.3M | 2 |
| 2022 | - | 3M | 1M | 1.8M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 13, 2024, Aminulla Bayankhail is registered as adm. dir. of PharmaGroup ApS.
As of December 13, 2024, Amar Fakhry Alaa Al Dyen-Ahmad has stepped down as director of PharmaGroup ApS.
PharmaGroup ApS has published its annual report for 2023. Gross profit came to DKK 8,771,950, and the net result was DKK 5,447,761.
About PharmaGroup ApS
PharmaGroup ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2022. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Amar Fakhry Alaa Al Dyen-Ahmad. The company is owned by PharmaGroup Holding ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 5,561,227 and a net result of DKK 2,366,747 compared with DKK 5,037,144 the year before. Equity in the 2025 report amounted to DKK 2,458,279.